InvestSMART

EBR Systems Inc (ASX:EBR)

ALERT: Price-sensitive ASX Announcement for EBR
Current share price for EBR : $0.230 -0.055 (-19.30%)+
Announcement
Release
12 Aug 2026 8:25AM
Price at Release
$0.285
Full Release
download
Summary
During Q2 2026, EBR Systems, Inc., a medical device company specializing in wireless cardiac pacing technology, made significant progress in commercial, operational, and financial areas. The company achieved its 100th commercial implant of the WiSE CRT System, secured key purchasing agreements, and advanced its manufacturing capabilities with a new facility in Santa Clara, CA. Financially, EBR completed two tranches of a $150 million capital raise to support its growth and pathway to cashflow breakeven. The U.S. Centers for Medicare & Medicaid Services initiated a National Coverage Determination process for the WiSE System, advancing EBR's reimbursement strategy. Despite net operating cash outflows, EBR reported increased gross margins due to improved manufacturing efficiencies. The company remains focused on scaling its operations and expanding its market presence.
Key Points
  • EBR partially completed a $150 million capital raise.
  • Achieved 100th commercial WiSE implant.
  • Secured purchasing agreements with major US healthcare networks.
  • Began transitioning to a new manufacturing facility.
  • U.S. CMS initiated National Coverage Determination process.
  • Net operating cash outflows of $17.2 million.
  • Gross margin improvement to 13%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.